Administrative-driven hierarchical management of atrial fibrillation on cardiovascular events: a prospective matched

Mu Chen1, Mingzhe Zhao1, Yuli Yang1

  • 1Department of Cardiology, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.

Nature Communications
|December 16, 2025
PubMed

Insights

The administrative-driven hierarchical management (ADHM) model significantly reduced cardiovascular events in atrial fibrillation (AF) patients. This approach also lowered medical costs, demonstrating its effectiveness in managing AF care.

Area of Science:

  • Cardiology
  • Public Health
  • Health Management

Background:

  • The administrative-driven hierarchical management (ADHM) model involves general practitioners acting as gatekeepers, incentivized by local government policies within a hierarchical medical system.
  • The impact of ADHM on cardiovascular events, specifically in atrial fibrillation (AF) patients, has not been clearly established.

Purpose of the Study:

  • To evaluate the effectiveness of the ADHM model in reducing cardiovascular events and healthcare costs among patients with atrial fibrillation (AF).

Main Methods:

  • A cohort study was conducted in Shanghai, China, enrolling 1455 AF patients in the ADHM cohort and 7275 matched patients in the usual care (UC) cohort.
  • Follow-up was conducted over 30 months, monitoring a primary composite outcome of ischemic stroke, systemic embolism, myocardial infarction, major bleeding, acute heart failure, and cardiovascular death, along with secondary endpoints and medical costs.

Main Results:

  • The ADHM cohort exhibited a significantly lower rate of the primary composite outcome compared to the UC cohort (HR: 0.624; 95% CI: 0.554-0.703; p < 0.0001).
  • Secondary endpoints, including all-cause death, cardiovascular death, ischemic stroke, and acute heart failure, were also reduced in the ADHM cohort. Rates of non-cardiovascular death, systemic embolism, myocardial infarction, and major bleeding were similar between groups.
  • The ADHM model resulted in lower medical costs per patient per survival day.

Conclusions:

  • The administrative-driven hierarchical management (ADHM) model is effective in decreasing cardiovascular events for patients diagnosed with atrial fibrillation (AF).
  • The ADHM approach also demonstrates cost-effectiveness, suggesting its value in managing AF care within healthcare systems.

Related Concept Videos

Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
264
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
198
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
293
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
411
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
253
Dysrhythmias VII: Nursing Management of Dysrhythmias01:25

Dysrhythmias VII: Nursing Management of Dysrhythmias

Nursing management of dysrhythmias involves the following:AssessmentSubjective Assessment:The initial step involves gathering patient-reported symptoms such as dizziness, palpitations, and chest discomfort. It is crucial to collect a detailed history, including previous heart conditions, current medication use, and lifestyle factors like caffeine and alcohol consumption.Objective Assessment:This involves observing clinical signs such as jugular venous distention, cool and pale skin, and...
346